Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)

NCT00249795 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9016

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Cardiovascular Disease

Interventions

DRUG: Irbesartan
DRUG: placebo

Sponsor

Sanofi

Collaborators

[object Object]